SCHEMBL7225638

SCHEMBL7225638

CC(=O)Nc1ccccc1Oc1ccc(C(=O)N[C@@H]2C[C@H]3CC[C@@H]2N3)s1

nearest known ligand 0.36

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.36
CHRNA7 P36544 3/20 0.35
ALDH1A1 P00352 1/20 0.34
CXCR2 P25025 1/20 0.34
BRD4 O60885 1/20 0.34
HTR3E A5X5Y0 2/20 0.33
HTR3B O95264 2/20 0.33
HTR3A P46098 2/20 0.33
HTR3D Q70Z44 2/20 0.33
HTR3C Q8WXA8 2/20 0.33
GAA P10253 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7224864 0.89 ANO1 (0.35) SMN1; SMN2CHRNA7CXCR2GAAPKM
SCHEMBL7232082 0.89 CXCR2 (0.34) SMN1; SMN2CHRNA7ALDH1A1CXCR2HTR3E
SCHEMBL7229598 0.89 ALDH1A1 (0.42) CHRNA7ALDH1A1CXCR2HTR3EHTR3B
SCHEMBL7232302 0.87 CHRNA7 (0.36) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7223853 0.87 CHRNA7 (0.43) SMN1; SMN2CHRNA7HTR3EHTR3BHTR3A
SCHEMBL7225513 0.87 CHRNA7 (0.37) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7224194 0.86 CHRNA7 (0.35) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7229885 0.85 SLC6A4 (0.39) CHRNA7
SCHEMBL7225949 0.85 CHRNA7 (0.35) CHRNA7HTR3EHTR3BHTR3AHTR3D
SCHEMBL7225732 0.84 SMN1; SMN2 (0.36) SMN1; SMN2CHRNA7ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US claimed
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US disclosed